Karolien Claes

3.3k total citations · 1 hit paper
27 papers, 2.5k citations indexed

About

Karolien Claes is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Karolien Claes has authored 27 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 12 papers in Epidemiology and 9 papers in Immunology. Recurrent topics in Karolien Claes's work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (10 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Karolien Claes is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Microscopic Colitis (10 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Karolien Claes collaborates with scholars based in Belgium, Hungary and Greece. Karolien Claes's co-authors include Séverine Vermeire, Marc Ferrante, Paul Rutgeerts, Marie Joossens, Vera Ballet, Jan Verhaegen, Kathleen Machiels, Filip Van Immerseel, Kristin Verbeke and João Sabino and has published in prestigious journals such as Gastroenterology, Gut and American Journal of Transplantation.

In The Last Decade

Karolien Claes

25 papers receiving 2.4k citations

Hit Papers

A decrease of the butyrate-producing species Roseburia ho... 2013 2026 2017 2021 2013 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
    2013 1.4k citations Kathleen Machiels, Marie Joossens et al. Gut profile →

Peers

Karolien Claes
Martina E. Spehlmann Germany
Guozhong Ji China
Laurence D. Jewell Canada
Alan Ebringer United Kingdom
Frank Seibold Switzerland
J Vilaseca Spain
A. S. Peña Netherlands
Daniela Carlos Brazil
Martin W. Laaß Germany
Akihiko Oka Japan
Martina E. Spehlmann Germany
Karolien Claes
Citations per year, relative to Karolien Claes Karolien Claes (= 1×) peers Martina E. Spehlmann

Countries citing papers authored by Karolien Claes

Since Specialization
Citations

This map shows the geographic impact of Karolien Claes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karolien Claes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karolien Claes more than expected).

Fields of papers citing papers by Karolien Claes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karolien Claes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karolien Claes. The network helps show where Karolien Claes may publish in the future.

Co-authorship network of co-authors of Karolien Claes

This figure shows the co-authorship network connecting the top 25 collaborators of Karolien Claes. A scholar is included among the top collaborators of Karolien Claes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karolien Claes. Karolien Claes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peetermans, Marijke, et al.. (2024). STEC colitis mimicking acute severe colitis with life-threatening consequences: a case report. Acta Gastro Enterologica Belgica. 87(1). 37–39.
2.
Billiet, Thomas, Isabelle Cleynen, Vera Ballet, et al.. (2017). Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn’s disease. Scandinavian Journal of Gastroenterology. 52(10). 1086–1092. 38 indexed citations
3.
Billiet, Thomas, Isabelle Cleynen, Vera Ballet, et al.. (2015). Disease burden outweighs the impact of drug concentrations and antibodies to infliximab in primary non-response to infliximab in Crohn's disease patients. 9. 2 indexed citations
4.
Papamichael, Konstantinos, Karolien Claes, Magali de Bruyn, et al.. (2015). Serology panel for prediction relapse after discontinuation of infliximab in patients with Crohn's disease achieving clinical remission. 9. 1 indexed citations
5.
Papamichael, Konstantinos, Thomas Van Stappen, Niels Vande Casteele, et al.. (2015). Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 14(4). 543–549. 127 indexed citations
6.
Ombelet, Sien, Eric Van Wijngaerden, Thomas Tousseyn, et al.. (2015). Mycobacterium genavense infection in a solid organ recipient: a diagnostic and therapeutic challenge. Transplant Infectious Disease. 18(1). 125–131. 13 indexed citations
7.
Papamichael, Konstantinos, Niels Vande Casteele, Thomas Billiet, et al.. (2015). Tu1286 Early Therapeutic Drug Monitoring for Prediction of Short-Term Mucosal Healing in Patients With Ulcerative Colitis Treated With Infliximab. Gastroenterology. 148(4). S–848. 2 indexed citations
8.
Machiels, Kathleen, Marie Joossens, João Sabino, et al.. (2013). A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 63(8). 1275–1283. 1423 indexed citations breakdown →
9.
Arias, M., Isabelle Cleynen, Karolien Claes, et al.. (2011). The Role of FC Gamma Receptor (FCGR) Mutations in the Response to Infliximab in Inflammatory Bowel Disease. Gastroenterology. 140(5). S–1. 2 indexed citations
10.
Κarmiris, Konstantinos, Gilles Paintaud, Maja Noman, et al.. (2009). Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease. Gastroenterology. 137(5). 1628–1640. 398 indexed citations
11.
Evenepoel, Pieter, Maarten Naesens, Karolien Claes, Dirk Kuypers, & Yves Vanrenterghem. (2007). Tertiary ‘Hyperphosphatoninism’ Accentuates Hypophosphatemia and Suppresses Calcitriol Levels in Renal Transplant Recipients. American Journal of Transplantation. 7(5). 1193–1200. 124 indexed citations
12.
Ferrante, Marc, Marieke Pierik, Liesbet Henckaerts, et al.. (2006). A panel of anti-glycan antibodies (gASCA, ALCA, ACCA and AMCA) in the diagnosis and differential diagnosis of IBD. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
13.
Henckaerts, Liesbet, Marieke Pierik, Karolien Claes, et al.. (2006). Mutations in innate immune receptors modulate the serologic response to microbial antigens in patients with inflammatory bowel disease. Gastroenterology. 130(4). 6 indexed citations
14.
Katsanos, Konstantinos, Marc Ferrante, Marie Joossens, et al.. (2006). The MDR1 G2677T polymorphism is associated with gastrointestinal intolerance to azathioprine. Gastroenterology. 130(4). 1 indexed citations
15.
Katsanos, K., Séverine Vermeire, Karolien Claes, et al.. (2006). Multi Drug Resistance Gene Single Nucleotide Polymorphisms in Inflammatory Bowel Disease. Annals of Gastroenterology. 19(1). 1 indexed citations
16.
Ferrante, Marc, Liesbet Henckaerts, Marie Joossens, et al.. (2006). The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease. Inflammatory Bowel Diseases. 12(9). 870–878. 48 indexed citations
17.
Lakatos, Péter L., Simon Fischer, Karolien Claes, et al.. (2006). DLG5 R30Q Is Not Associated With IBD in Hungarian IBD Patients but Predicts Clinical Response to Steroids in Crohn's Disease. Inflammatory Bowel Diseases. 12(5). 362–368. 20 indexed citations
18.
Fischer, Simon, Karolien Claes, L. Lakatos, et al.. (2006). DLG5 R30Q does not predict response to infliximab therapy in Hungarian patients with Crohn's disease. Zeitschrift für Gastroenterologie. 44(5).
19.
Evenepoel, Pieter, Karolien Claes, Dirk Kuypers, et al.. (2004). Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrology Dialysis Transplantation. 19(5). 1281–1287. 231 indexed citations
20.
Kuypers, Dirk, Karolien Claes, Pieter Evenepoel, Bart Maes, & Yves Vanrenterghem. (2003). Long-Term Pharmacokinetic Study of the Novel Combination of Tacrolimus and Sirolimus in De Novo Renal Allograft Recipients. Therapeutic Drug Monitoring. 25(4). 447–451. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina E. Spehlmann Breakdown of academic impact, for papers by Guozhong Ji Breakdown of academic impact, for papers by Laurence D. Jewell Breakdown of academic impact, for papers by Alan Ebringer Breakdown of academic impact, for papers by Frank Seibold Breakdown of academic impact, for papers by J Vilaseca Breakdown of academic impact, for papers by A. S. Peña Breakdown of academic impact, for papers by Daniela Carlos Breakdown of academic impact, for papers by Martin W. Laaß Breakdown of academic impact, for papers by Akihiko Oka
Rankless by CCL
2026